Live feed
Filing
SC 13G/A
SC 13G/A0000899140-23-000400·Avalo Therapeutics, Inc.
Schedule 13G ownership disclosure
Avalo Therapeutics Inc
Security class unavailable · CUSIP: 05338F207
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 500,737
- Percent of class
- 5.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-23-000400
- Form type
- SC 13G/A
- Filer
- Avalo Therapeutics, Inc.
- CIK
- CIK 1534120
- Filed
- Feb 14, 2023
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership